Diabetes Treatment Advances: Top Findings from ADA Annual Conference Day 2
Triple Hormone Receptor Obesity Drug Faces Regulatory Crossroads Amid Mixed Trial Outcomes Published this week at the American Diabetes Association conference, a monthly obesity drug targeting triple hormone receptors has ... Read More